GA
General Atlantic Portfolio holdings
AUM
$3.63B
This Quarter Return
+10.59%
1 Year Return
+68.62%
3 Year Return
+215.99%
5 Year Return
+161.66%
10 Year Return
+1,026.7%
AUM
$3.63B
AUM Growth
+$3.63B
(+22%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
11.29%
Top 10 Holdings %
Top 10 Hldgs %
97.39%
Holding
18
New
3
Increased
1
Reduced
2
Closed
3
Top Buys
| 1 |
CHYM
Chime Financial, Inc. Class A Common Stock
CHYM
|
$663M |
| 2 |
BULL
Webull Corporation Class A Ordinary Shares
BULL
|
$85.5M |
| 3 |
Akero Therapeutics
AKRO
|
$26.7M |
| 4 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$3.89M |
Top Sells
| 1 |
Alignment Healthcare
ALHC
|
$238M |
| 2 |
XP
XP
|
$82.8M |
| 3 |
Immunocore
IMCR
|
$37.4M |
| 4 |
SLRN
ACELYRIN
SLRN
|
$6.66M |
| 5 |
LOGC
ContextLogic
LOGC
|
$4.26M |
Sector Composition
| 1 | Technology | 49.33% |
| 2 | Healthcare | 34.36% |
| 3 | Financials | 14.2% |
| 4 | Consumer Staples | 2.11% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
dLocal
DLO
$4.25B
| $725M | 19.97% | 63,906,695 | – | – |
|
|
CHYM
2
Chime Financial, Inc. Class A Common Stock
CHYM
$9.82B
| $663M | 18.26% | +19,208,760 | New | +$663M |
|
|
3
Alignment Healthcare
ALHC
$3.24B
| $616M | 16.97% | 43,993,323 -17,000,000 | -28% | -$238M |
|
|
4
XP
XP
$9.56B
| $515M | 14.2% | 25,517,733 -4,100,000 | -14% | -$82.8M |
|
|
5
Akero Therapeutics
AKRO
$3.74B
| $306M | 8.43% | 5,733,989 +500,000 | +10% | +$26.7M |
|
6
Alkami Technology
ALKT
$2.66B
| $291M | 8.01% | 9,645,318 | – | – |
|
7
Pharvaris
PHVS
$1.39B
| $133M | 3.65% | 7,531,252 | – | – |
|
|
CNTA
8
Centessa Pharmaceuticals
CNTA
$2.25B
| $127M | 3.51% | 9,681,818 | – | – |
|
|
BULL
9
Webull Corporation Class A Ordinary Shares
BULL
$6.59B
| $85.5M | 2.36% | +7,148,051 | New | +$85.5M |
|
10
European Wax Center
EWCZ
$186M
| $73.8M | 2.03% | 13,110,492 | – | – |
|
11
Royalty Pharma
RPRX
$15.6B
| $54M | 1.49% | 1,500,000 | – | – |
|
12
Riskified
RSKD
$748M
| $26.6M | 0.73% | 5,324,998 | – | – |
|
|
ADAG
13
Adagene
ADAG
$100M
| $7.46M | 0.21% | 3,825,952 | – | – |
|
|
ALMS
14
Alumis Inc. Common Stock
ALMS
$479M
| $3.89M | 0.11% | +1,297,530 | New | +$3.89M |
|
15
Grove Collaborative
GROV
$62.3M
| $2.85M | 0.08% | 2,474,859 | – | – |
|
|
16
Immunocore
IMCR
$1.62B
| – | – | -1,261,684 | Closed | -$37.4M |
|
|
SLRN
17
DELISTED
ACELYRIN
SLRN
| – | – | -2,695,327 | Closed | -$6.66M |
|
|
LOGC
18
DELISTED
ContextLogic
LOGC
| – | – | -609,616 | Closed | -$4.26M |
|